The pharmaceutical industry is undergoing an enormous shift in structure and strategy to reinvent how to bring new drugs to market efficiently. Hans Constandt at Ontoforce explains global drug development strategies – consolidation and partnerships, functional outsourcing relationships, innovation networks, expansion into emerging markets, orphan drugs, translational science, academic alliances and use of public private partnerships (PPP) – all reflect new thinking aimed at achieving higher R&D efficiency and greater return on investment.
https://international-pharma.com/wp-content/uploads/2013/10/Distruptive-Change1.pdf